Schlatter Industries AG (STRN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 20.20 |
|---|---|
| 52-week range | 17.30 – 22.00 |
| Return, 1 month / 3 months | +9.2% / +8.6% |
| Return, 1 year / 3 years | −1.0% / −6.5% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 43.7% |
| Worst drawdown (1 year) | -19.0% |
| Average daily value traded | 0.02M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Schlatter Industries is a Swiss engineering firm based in Schlieren that builds machinery for welding and wire processing. Its resistance welding systems join wire, mesh and metal components, and its equipment helps manufacturers produce reinforcement mesh, fencing and similar wire products. Customers are industrial manufacturers and construction-related suppliers who need reliable production machinery. The company also provides related services and spare parts for its installed machines, supporting customers who run its equipment in their factories.
Schlatter Industries AG trades under the code STRN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Schlatter Industries AG (STRN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 20.20 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 146 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.0% and over the last three months it rose 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.9% | ||
| From 52-week high | -8.2% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.6% | ||
| 6-month return | 9.2% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.0% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M CHF | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | +9.2% |
| 3 months | +8.6% |
| 6 months | +9.2% |
| 1 year | −1.0% |
| 3 years | −6.5% |
| 5 years | −17.5% |
Signals
| 50-day / 200-day average | 19.03 / 19.07 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2025 | CHF 0.5000 |
| 14 May 2024 | CHF 1.0000 |
| 8 May 2023 | CHF 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.